ABT Earnings Preview: Options Price a ±6.4% Move
· The NYC Memo · ABT reports 2026-10-21
Abbott Laboratories reports October 21, 2026. The October 23, 2026 straddle implies ±6.44% against a 7.41% average reaction, with dealers short gamma and max pain at $103.
Live updates
Oct 21 — implied move ±5.53% to ±6.44%; ATM implied vol 68.7% to 98.9%; spot $104.06 to $102.45; max pain $104 to $103; net dealer gamma $1mn to $-6mn; put/call open interest 1.24 to 1.69. The straddle now prices ±6.44% with ABT at $102.45 and dealers short gamma.
Oct 20 — ATM implied vol 60.9% to 68.7%; max pain $101 to $104; put/call open interest 1.35 to 1.24. The straddle now prices ±5.53% with ABT at $104.06 and dealers long gamma.
Abbott Laboratories reports Q3 2026 results on October 21, 2026, before open. The October 23, 2026 straddle is priced at $6.60, an implied move of ±6.44% against an average realised reaction of 7.41% over the last 4 prints. The stock trades at $102.45, -22.4% from its 52-week high, with dealers short gamma and max pain at $103.
What the options market is pricing
| Measure | Level |
|---|---|
| October 21, 2026, Before Open | |
| Expiry used | October 23, 2026 (2 days out) |
| Spot | $102.45 |
| ATM straddle | $6.60 |
| Implied move | ±6.44% ($95.85 to $109.05) |
| ATM implied vol | 98.9% |
| Put/call open interest | 1.69 |
| Max pain | $103 |
| Net dealer gamma | -$6mn per 1% move, SHORT GAMMA |
| Heaviest call strike above spot | $107 (1,509 contracts) |
| Heaviest put strike below spot | $94 (1,840 contracts) |
| Street EPS estimate | $1.43 |
| Street revenue estimate | $13.13bn |
Dealers sit short gamma into the print, so their hedging chases direction. A surprise in either tail gets amplified rather than absorbed.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Jul 16 | +10.71% |
| Q1 2026, Apr 16 | -6.00% |
| Q4 2025, Jan 22 | -10.04% |
| Q3 2025, Oct 15 | -2.87% |
Across the last 4 prints the average absolute reaction is 7.41%, with 1 higher and 3 lower. The best was +10.71% and the worst -10.04%. Options are asking ±6.44%, which is 0.97 points cheaper than the realised average, the premium buyer's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $102.45 |
| 52-week range | $81.97 to $132.03 |
| Position in that range | 41% |
| From the 52-week high | -22.4% |
| From the 52-week low | +25.0% |
| Past week | -0.2% |
| Past month | -0.5% |
| Past three months | +1.9% |
| 50-day average | $105.67 |
| 200-day average | $102.59 |
Unusual open interest
| Contract | Open interest | Signal |
|---|---|---|
| $125 call, Dec 18 | 2,532 contracts | oi zscore, 17.0 sigma |
| $90 put, Jan 15 | 1,891 contracts | oi zscore, 8.0 sigma |
| $90 put, Mar 19 | 2,605 contracts | oi zscore, 6.3 sigma |
| $110 call, Nov 20 | 8,860 contracts | oi zscore, 3.3 sigma |
Those are the strikes where positioning built fastest relative to their own history. They mark the levels the tape is most likely to defend or chase after the print.
How the options market is pricing it
The October 23, 2026 straddle marks $95.85 to $109.05 as the range the options market is paying for into the print, with ATM implied vol at 99% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ABT has moved 7.41% on earnings against the ±6.44% now implied, so the market is pricing this print cheaper than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ABT before the print.
Data as of October 21, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ABT options memo